Department of Obstetrics and Gynaecology, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.
Cochrane Thailand, Khon Kaen University, Khon Kaen, Thailand.
Cochrane Database Syst Rev. 2022 May 18;5(5):CD013565. doi: 10.1002/14651858.CD013565.pub2.
Contraceptive implants are one of the most effective contraceptive methods, providing a long duration of pregnancy protection and a high safety profile. Hence this method is suitable for optimizing the interpregnancy interval, especially for women undergoing abortion. Women who have had abortions are at high risk of rapid repeat pregnancies. Provision of effective contraception at the time of an abortion visit can be a key strategy to increase access and uptake of contraception. A review of the evidence was needed to evaluate progestin-releasing implants for immediate use at the time of abortion, including whether immediate placement impacts the effectiveness of medical abortion, which relies on antiprogestogens.
To compare contraceptive implant initiation rates, contraceptive effectiveness, and adverse outcomes associated with immediate versus delayed insertion of contraceptive implants following abortion.
We searched for all relevant studies regardless of language or publication status up to September 2019, with an update search in March 2021. We searched the Cochrane Central Register of Controlled Trials (CENTRAL) (Ovid EBM Reviews), MEDLINE ALL (Ovid), Embase.com, CINAHL (EBSCOhost) (Cumulative Index to Nursing and Allied Health Literature), Global Health (Ovid), LILACS (Latin American and Caribbean Health Science Information database), Scopus, ClinicalTrials.gov, and the WHO ICTRP. We examined the reference lists of pertinent articles to identify other studies.
We sought randomized controlled trials (RCTs) comparing immediate versus delayed insertion of contraceptive implant for contraception following abortion.
We followed the standard procedures recommended by Cochrane. To identify potentially relevant studies, two review authors (JS, LS) independently screened the titles, abstracts, and full texts of the search results, assessed trials for risk of bias, and extracted data. We computed the risk ratio (RR) with 95% confidence intervals (CIs) for binary outcomes, and the mean difference (MD) with 95% CIs for continuous variables.
We found three RCTs including a total of 1162 women. Our GRADE assessment of the overall certainty of the evidence ranged from moderate to very low, downgraded for risk of bias, inconsistency, and imprecision. Utilization rate at six months may be slightly higher for immediate compared with delayed insertion (RR 1.10, 95% CI 1.05 to 1.15; 3 RCTs; 1103 women; I = 62%; low certainty evidence). Unintended pregnancy within six months after abortion was probably lower with immediate insertion compared with delayed insertion (RR 0.25, 95% CI 0.08 to 0.77; 3 RCTs; 1029 women; I = 0%; moderate certainty evidence). Immediate insertion of contraceptive implants probably improves the initiation rate compared to delayed insertion following medical abortion (RR 1.26 for medical abortion, 95% CI 1.21 to 1.32; 2 RCTs; 1014 women; I = 89%; moderate certainty evidence) and may also improve initiation following surgical abortion (RR 2.32 for surgical abortion, 95% CI 1.79 to 3.01; 1 RCT; 148 women; I = not applicable; low certainty evidence). We did not pool results for the implant initiation outcome over both abortion types because of very high statistical heterogeneity. For medical termination of pregnancy, we found there is probably little or no difference between immediate and delayed insertion in overall failure of medical abortion (RR 1.18, 95% CI 0.58 to 2.40; 2 RCTs; 1001 women; I = 68%;moderate certainty evidence). There may be no difference between immediate and delayed insertion on rates of abnormal bleeding at one month after abortion (RR 1.00, 95% CI 0.88 to 1.14; 1 RCT; 462 women; I = not applicable; low certainty evidence).
AUTHORS' CONCLUSIONS: Provision of progestin-releasing implants concurrently with abortifacient agents likely has little or no negative impact on overall failure rate of medical abortion. Immediate insertion probably improves the initiation rate of contraceptive implant, as well as unintended pregnancy rate within six months after abortion, compared to delayed insertion. There may be no difference between immediate and delayed insertion approaches in bleeding adverse effects at one month after abortion.
避孕植入物是最有效的避孕方法之一,提供了长时间的妊娠保护和高安全性。因此,这种方法适合优化产后间隔,特别是对于经历过流产的女性。经历过流产的女性有快速重复怀孕的高风险。在流产就诊时提供有效的避孕措施可能是增加避孕措施获取和使用的关键策略。需要对证据进行审查,以评估孕激素释放植入物在流产时的即时使用,包括即时放置是否会影响依赖抗孕激素的药物流产的有效性。
比较即时与延迟放置避孕植入物在流产后对避孕植入物起始率、避孕效果和不良结局的影响。
我们搜索了所有相关研究,无论语言或出版状态如何,截止日期为 2019 年 9 月,并于 2021 年 3 月进行了更新搜索。我们在考科蓝中心对照试验注册库(CENTRAL)(Ovid EBM Reviews)、MEDLINE ALL(Ovid)、Embase.com、CINAHL(EBSCOhost)(护理与联合健康文献累积索引)、全球卫生(Ovid)、LILACS(拉丁美洲和加勒比卫生科学信息数据库)、Scopus、ClinicalTrials.gov 和世界卫生组织国际临床试验注册平台(WHO ICTRP)中进行了搜索。我们还查阅了相关文章的参考文献,以确定其他研究。
我们寻求比较即时与延迟放置避孕植入物在流产后避孕的随机对照试验(RCTs)。
我们遵循考科蓝推荐的标准程序。为了确定潜在的相关研究,两位综述作者(JS、LS)独立筛选了搜索结果的标题、摘要和全文,评估了试验的偏倚风险,并提取了数据。我们计算了二分类结局的风险比(RR)及其 95%置信区间(CI),计算了连续变量的均数差(MD)及其 95%CI。
我们发现了三项 RCTs,共纳入了 1162 名女性。我们对证据的总体确定性评估范围从低到高,因偏倚风险、不一致性和不精确性而降低。与延迟放置相比,即时放置可能在六个月时的利用率稍高(RR 1.10,95%CI 1.05 至 1.15;3 项 RCTs;1103 名女性;I = 62%;低确定性证据)。与延迟放置相比,即时放置可能使流产后六个月内的意外怀孕率降低(RR 0.25,95%CI 0.08 至 0.77;3 项 RCTs;1029 名女性;I = 0%;中等确定性证据)。与延迟放置相比,即时放置可能会提高药物流产后(RR 1.26,95%CI 1.21 至 1.32;2 项 RCTs;1014 名女性;I = 89%;中等确定性证据)和手术流产后(RR 2.32,95%CI 1.79 至 3.01;1 项 RCT;148 名女性;I = 不适用;低确定性证据)的避孕植入物起始率。由于高度的统计学异质性,我们没有对两种流产类型的避孕起始结果进行汇总。对于药物终止妊娠,我们发现即时和延迟放置在药物流产的总体失败方面可能没有差异(RR 1.18,95%CI 0.58 至 2.40;2 项 RCTs;1001 名女性;I = 68%;中等确定性证据)。即时和延迟放置在流产后一个月的异常出血率方面可能没有差异(RR 1.00,95%CI 0.88 至 1.14;1 项 RCT;462 名女性;I = 不适用;低确定性证据)。
在流产时同时使用孕激素释放剂可能对药物流产的总体失败率几乎没有或没有负面影响。即时放置可能会提高避孕植入物的起始率,以及流产后六个月内的意外怀孕率,与延迟放置相比。即时和延迟放置方法在流产后一个月的出血不良事件方面可能没有差异。